Mustang Bio (MBIO) Accumulated Expenses (2018 - 2026)

Mustang Bio (MBIO) has reported Accumulated Expenses for 9 consecutive years, with $160000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Expenses fell 89.38% year-over-year to $160000.0; the TTM figure through Mar 2026 stood at $160000.0 (down 89.38% YoY), while the FY2025 annual figure was $24000.0, down 98.5% from the prior year.
• Accumulated Expenses grew to $160000.0 in Q1 2026 per MBIO's latest filing, from $24000.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $2.7 million in Q2 2022 and bottomed at $24000.0 in Q4 2025.
• Historically, Accumulated Expenses has averaged $1.2 million across 5 years, with a median of $1.2 million in 2024.
• Annual changes were most pronounced in 2022 — Accumulated Expenses surged 970.08% — and 2025, when it sank 98.5%.
• Mustang Bio's Accumulated Expenses stood at $648000.0 in 2022, then increased by 14.04% to $739000.0 in 2023, then surged by 116.37% to $1.6 million in 2024, then tumbled by 98.5% to $24000.0 in 2025, then surged by 566.67% to $160000.0 in 2026.
• Business Quant data shows MBIO's Accumulated Expenses at $160000.0 in Q1 2026, $24000.0 in Q4 2025, and $1.5 million in Q3 2025.